Mitochondrial Strategies in Ferroptotic Cell Death

Mito-FerroQuest aims to explore mitochondrial communication and CoQ's role in preventing ferroptosis, potentially leading to new therapies for neurodegenerative disorders.

Subsidie
€ 1.500.000
2025

Projectdetails

Introduction

Mitochondria serve as the epicenter of cellular metabolism. Their dynamic communication with other compartments within the cell ensures proper cellular function. My recent work reveals how mitochondria communicate with the plasma membrane (PM) to transport a redox-active lipid Coenzyme Q (Ubiquinone or CoQ).

Importance of Coenzyme Q

This communication is crucial for inhibiting a form of iron-mediated cell death called ferroptosis. Notably, CoQ is exclusively synthesized within the mitochondria and plays a pivotal role in maintaining the mitochondrial respiratory chain, as well as other metabolic pathways, such as:

  1. Pyrimidine synthesis
  2. Fatty acid oxidation
  3. Proline metabolism

My work highlights that cellular defense is primarily orchestrated from the mitochondria and surprisingly dependent on a molecule—CoQ—that is indispensable for mitochondrial function.

Mitochondrial Defense Mechanisms

This work shows that mitochondria—known as cell death inducers—protect cells from ferroptosis and opens several key questions that I will address in Mito-FerroQuest, including:

i) Which proteins and metabolic pathways within the mitochondria dictate whether CoQ should be exported or retained within the mitochondria?
ii) Do mitochondria have other ways to defend against ferroptosis, or is CoQ export their only defense?
iii) Does mitochondrial communication extend beyond the PM and involve interactions with other organelles, such as the endoplasmic reticulum (ER), in protecting cells against ferroptosis?

Future Implications

Answers to these questions will enhance our understanding of mitochondrial strategies in ferroptosis, potentially paving the way for new therapies in conditions where ferroptosis is implicated, like neurodegenerative disorders.

Research Goals

Mito-FerroQuest sets the stage for my overarching goal of exploring ferroptosis in diseases with compromised mitochondrial function, such as Leigh syndrome, with the aim to assess its potential as a therapeutic target.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 1.500.000
Totale projectbegroting€ 1.500.000

Tijdlijn

Startdatum1-1-2025
Einddatum31-12-2029
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBHpenvoerder

Land(en)

Germany

Vergelijkbare projecten binnen European Research Council

ERC Consolid...

Deciphering and exploiting ferroptosis regulatory mechanism in cancer

DeciFERR aims to uncover mechanisms regulating ferroptosis to develop targeted therapies for challenging cancers like neuroblastoma by focusing on lipid oxidation pathways and key suppressors.

€ 1.985.356
ERC Advanced...

When enzymes join forces: unmasking a mitochondrial biosynthetic engine

This project aims to reconstitute and characterize a biosynthetic pathway for coenzyme Q within a metabolon, revealing enzyme interactions and evolutionary transitions in crowded cellular environments.

€ 2.107.750
ERC Advanced...

Mitochondrial Precursor Proteins in the Cytosol as Major Determinants of Cellular Health

MitoCyto aims to uncover the biology of cytosolic mitochondrial precursor proteins using innovative interdisciplinary techniques to enhance understanding of cellular proteostasis and its implications for aging and neurodegeneration.

€ 2.334.450
ERC Proof of...

A companion magnetic sensor for in operando detection of magnetic biosynthesis in cancer and neurodegenerative models

The BioMag PoC project aims to develop a sensitive magnetic sensor for real-time monitoring of intracellular magnetic iron biosynthesis, potentially leading to novel therapies for cancer and Alzheimer's.

€ 150.000
ERC Advanced...

Mitochondrial gene eXpression

This project aims to elucidate the mechanisms regulating mitochondrial gene expression by investigating transcript interactomes and translation dynamics in both organello and in vivo contexts.

€ 1.913.968